Adma Biologics Inc Reports Results For The Quarter Ended In March: Earnings Summary

ADMA Biologics

11/05/2022 23:45

* ADMA Biologics Inc  ADMA.OQ  reported a quarterly adjusted
loss
of 10 cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 8
cents per share.
    * Revenue rose 81.3% to $29.10 million from a year ago; 
analysts
expected $28.15 million. 
    * ADMA Biologics Inc's reported EPS for the quarter was a
loss
of 13 cents​.
    * The mean earnings estimate of analysts had fallen by
about 21.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * ADMA Biologics Inc shares had fallen by 12.0% this
quarter and
gained 14.2% so far this year.
    * The company reported a quarterly loss of $25.01 million.
    * Wall Street's median 12-month price target for ADMA
Biologics
Inc is $5.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 11 at 10:45 p.m.  ​All
figures in US dollars unless otherwise stated